MSN Home  |  My MSN  |  Hotmail
Sign in to Windows Live ID Web Search:   
go to MSNGroups 
Free Forum Hosting
 
Important Announcement Important Announcement
The MSN Groups service will close in February 2009. You can move your group to Multiply, MSN’s partner for online groups. Learn More
A Peaceful Place[email protected] 
  
What's New
  
  �?•�?·´`·.·�? �?/A>  
  Copyrights  
  Disclaimer  
  �?•�?·´`·.·�? �?/A>  
  Messages  
  General  
  Articles - Misc.  
  ADHD,ADD, Autism  
  �?Allergies �?/A>  
  Alternative & +  
  § Arthritis §  
  Depression  
  �?Diet �?/A>  
  �?Exercise �?/A>  
  Eyes  
  Fitness and Exercise  
  �? FM & CF �?/A>  
  Headaches  
  Herbs etc  
  IBS & Other DD's  
  �?•�?·´`·.·�?�?/A>  
  Liver  
  Lung Health  
  MS �?/A>  
  ◄Mycoplasms�?/A>  
  Osteoporosis  
  Pain-Coping  
  Skin Disorders  
  Sleep  
  �?Supplements  
  �?Toxins �?/A>  
  Humor �?/A>  
  Household ☼¿☼  
  Mind-Body-Spirit  
  Pictures  
    
  �?Links �?/A>  
  Snags  
  Sources & Resources  
  ≈☆≈E-Cards ≈☆�?/A>  
  Pesticides Exp  
  �?Organic Living  
  Organic Gardens  
  See the Most Recent Posts  
  
  
  Tools  
 
Herbs etc : Curcumin - Turmeric
Choose another message board
 
     
Reply
 Message 1 of 11 in Discussion 
From: Rene  (Original Message)Sent: 9/22/2005 7:13 PM

 

Curcumin May Be an Effective Therapy for Inflammatory Bowel Disease

Abstract:
Inflammatory bowel disease (IBD) refers to Crohn's disease and ulcerative
colitis, debilitating illnesses characterized by chronic recurrent ulceration of
the bowel, abdominal pain, digestive problems, diarrhea or constipation. In a
new study, researchers have shown that curcumin, a component of the spice
turmeric, holds promise as a treatment for severe inflammatory bowel problems.

My Excerpts:

08-27-2003, August 25, 2003 (Bethesda, MD) –�?Inflammatory bowel disease (IBD) refers to Crohn's disease and ulcerative colitis, debilitating illnesses characterized by chronic recurrent ulceration of the bowel, abdominal pain, digestive problems, diarrhea or constipation. The National Institutes of Health estimates that some two million Americans suffer from this disorder, which is of unknown origin, but likely caused by a combination of genetic, environmental, and immunologic factors.

Medical researchers have made considerable efforts to establish a genetic linkage between Crohn's disease and the NOD2 protein associated with programmed cell death and activation of NF- B, a transcription factor involved in the production of cytokines and chemokines necessary for inflammation.

Regulation of NF- B function has been documented by several agents used in the management of IBD, such as corticosteroids, sulfasalazine, and 5-aminosalicylates (5-ASA). Furthermore, antisense oligonucleotides directed against the p65 subunit (a polypeptide contributing to the activation of NF- B) have been shown to diminish disease activity in an animal model of colitis. Recent work has shown that dietary constituents such as curcumin may also potently inhibit NF- B and diminish attenuate proinflammatory molecule expression.

Curcumin is a component of the spice turmeric (Curcuma longa) used in curries and mustard, whose anti-inflammatory properties have been recognized for years. These effects are related, in part, to inhibition of the activities of the cyclooxygenase, lipoxygenase, and NF- B in several cell systems. Furthermore, its role in the attenuation of colonic cancer in animal models has also been established.

Management of IBD involves the use of 5-ASA and immunosuppressives such as corticosteroids and 6-mercaptopurine as well as its precursor azathioprine. Novel agents such as monoclonal antibodies against TNF- have been developed and demonstrate clinical efficacy. However, these agents are expensive and not without side effects.

Consequently, there is a need for alternative agents that may be equally or more effective as well as being cheaper. Both curcumin and sulfasalazine target IKK molecules; the importance of inhibition of IkB Kinase complex by curcumin has never been tested in IBD. Here researchers show that this compound has beneficial effects in a rat model of IBD, opening the door to possible future human studies.

Results

This animal study produced several key findings:
�?Curcumin attenuates macroscopic damage in murine colitis. Animals were weighed daily after induction of colitis and the data shown are representative of all experiments. There was a clear reduction in the amount of weight loss in the animals pretreated with curcumin.
�?Curcumin improves intestinal cell function in DNB-induced colitis. .... There was mucosal ulceration, thickening of the wall, and significant infiltration with inflammatory cells in the DNB-treated animals that is reduced in those animals pretreated with curcumin.
�?When animals were pretreated with curcumin, there was a clear reduction in DNA binding, thus verifying that curcumin does indeed inhibit NF- B activation in the colon in vivo. These findings indicate for the first time that curcumin is able to impact on an important transcriptional mechanism in the gastrointestinal tract.
�?Curcumin attenuates activation of p38 MAPK antibodies.


http://go1.warp9ems.com/go.pl?tu=33982215-15636

 



First  Previous  2-11 of 11  Next  Last 
Reply
 Message 2 of 11 in Discussion 
From: ReneSent: 10/27/2005 11:58 PM
 


  2005-07-14

Potent Spice Works

To Block Growth Of Melanoma In Lab Test

HOUSTON - Curcumin, the pungent yellow spice found in both turmeric and curry powders, blocks a key biological pathway needed for development of melanoma and other cancers, say researchers from The University of Texas M. D. Anderson Cancer Center.

 
The study, to be published in the August 15, 2005 issue of the journal Cancer, but available on line at 12:01 a.m. (EDT) on Monday, July 11, demonstrates how curcumin stops laboratory strains of melanoma from proliferating and pushes the cancer cells to commit suicide.

It does this, researchers say, by shutting down nuclear factor-kappa B (NF-kB), a powerful protein known to promote an abnormal inflammatory response that leads to a variety of disorders, including arthritis and cancer.

The study is the latest to suggest that curcumin has potent anticancer powers, say the researchers.

"The antioxidant, anti-inflammatory and anti-carcinogenic properties of curcumin derived from turmeric are undergoing intense research here and at other places worldwide," says one of the study's authors, Bharat B. Aggarwal, Ph.D., professor of cancer medicine in the Department of Experimental Therapeutics.

At M. D. Anderson, for example, dramatic results from laboratory studies have led to two ongoing Phase I human clinical trials, testing the ability of daily capsules of curcumin powder to retard growth of pancreatic cancer and multiple myeloma. Another Phase I trial is planned for patients with breast cancer, and given this news of curcumin's activity in melanoma, animal studies will soon begin, Aggarwal says.

Ground from the root of the Curcuma longa plant, curcumin is a member of the ginger family. It has long been utilized in India and other Asian nations for multiple uses: as a food-preservative, a coloring agent, a folk medicine to cleanse the body, and as a spice to flavor food (two to five percent of turmeric is curcumin, for example).

While researchers had thought curcumin primarily has anti-inflammatory properties, the growing realization that cancer can result from inflammation has spurred mounting interest in the spice as an anti-cancer agent, Aggarwal says. He adds that another fact has generated further excitement: "The incidence of the top four cancers in the U.S. - colon, breast, prostate, and lung - is ten times lower in India," he says.

This work is just the latest by M. D. Anderson researchers to show how curcumin can inhibit cancer growth. "Curcumin affects virtually every tumor biomarker that we have tried," says Aggarwal. "It works through a variety of mechanisms related to cancer development. We, and others, previously found that curcumin down regulates EGFR activity that mediates tumor cell proliferation, and VEGF that is involved in angiogenesis. Besides inhibiting NF-kB, curcumin was also found to suppress STAT3 pathway that is also involved in tumorigenesis. Both these pathways play a central role in cell survival and proliferation."

He said that an ability to suppress numerous biological routes to cancer development is important if an agent is to be effective. "Cells look at everything in a global way, and inhibiting just one pathway will not be effective," says Aggarwal.

In this study, the researchers treated three different melanoma cell lines with curcumin and assessed the activity of NF-kB, as well the protein, known as "IKK" that switches NF-kB "on." The spice kept both proteins from being activated, so worked to stop growth of the melanoma, and it also induced "apoptosis," or programmed death, in the cells.

Surprisingly, it didn't matter how much curcumin was used, says the researchers. "The NF-kB machinery is suppressed by both short exposures to high concentrations of curcumin as well as by longer exposure to lower concentrations of curcumin," they say in their study. Given that other studies have shown curcumin is non-toxic, these results should be followed by a test of the spice in both animal models of melanoma and in human trials, they say.

###
The study was funded by the National Cancer Institute and the Department of Defense. Co-authors included principle investigator Razelle Kurzrock, M.D.; first author Doris Siwak, Ph.D. and Shishir Shishodia.

http://www.sciencedaily.com/releases/2005/07/050712232338.htm


Reply
 Message 3 of 11 in Discussion 
From: ReneSent: 1/27/2006 6:39 PM
 


Spice Up Your Brain

Researchers looking for ways to fight Alzheimer's disease are hopeful that one answer might be found in a simple bowl of curry. That's because curcumin, a compound found in the curry spice turmeric, reduces the buildup of amyloid protein plaque that is associated with the disease.

That could explain why rates of Alzheimer's, which robs people of their memory and their ability to live fully and independently, are among the lowest in the world in India, where the spice is a dietary staple.

In a recent study on rats, scientists found that curcumin significantly reduced the buildup of beta-amyloid protein in the synapses, or gaps, between brain cells. These synapses connect nerve cells and are critical for memory.

Curcumin at work

Curcumin, and turmeric itself, have powerful antioxidant and anti-inflammatory properties, says David Winston, a registered herbalist and dean of the Herbal Therapeutics School of Botanic Medicine in Broadway, New Jersey. According to Winston, scientists already found that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen reduce the risk for Alzheimer's, but not without side effects such as gastric bleeding.

Studies on rats and mice show that curcumin works similarly to NSAIDs but without side effects, reducing brain inflammation and decreasing the oxidized proteins that form harmful plaque. Researchers think the compound will have similar effects in humans.

Dietary antioxidants protect against chronic inflammation and oxidative diseases, says Winston. He recommends that people incorporate a variety of antioxidants into their diet, including turmeric, rosemary and blueberries. Additionally, ginkgo biloba increases circulation and reduces oxidative processes in the brain.

Eating curcumin or turmeric on a regular basis seems to be helpful, but if you don't like it, don't worry. You can take a curcumin or turmeric supplement, says Winston. He prefers turmeric, since it may provide more antioxidant constituents than curcumin. Plus, curcumin can cause stomach irritation in some people, he cautions.

Winston suggests three different ways to get your curcumin...

  1. Turmeric capsules. Take two capsules, two to three times a day.
  2. Curcumin tincture. Take 3 milliliters (ml) to 4 ml, three times a day.
  3. Supplemental curcumin. Take between 1,200 mg and 1,800 mg a day, in three divided doses. Caution: Individuals prone to bleeding or on blood thinners should not take turmeric. Remember to stop using 10 to 14 days before any dental or surgical procedure.

While you're keeping your pathways clean, don't forget to keep your mind active. Research has shown that your brain creates new pathways when you learn something new.

Be well, Carole Jackson, Bottom Line's Daily Health News, Sept/05

 

 

Reply
 Message 4 of 11 in Discussion 
From: ReneSent: 4/28/2006 4:51 PM
 


CURCUMIN
A Powerful and Natural Cancer-Fightng Substance
The Following is a summary of the Laboratory Studies that are showing Curcumin induces many biological effects that fight the development and proliferation of cancer cells


Suppressing nuclear factor kappa beta (NF-KB). Cancer cells often over-express NF-KB and use this as a means to proliferate. Curcumin has been shown to suppress NF-KB.

Blocking cancer-mimicking chemicals that promote cancer growth. Curcumin blocks estrogen and estogen-mimicking chemicals that promote cell mutation and proliferation. These chemicals are found in our environment and are encounctered daily and include paraquat, a weed killer, notrosamines in cooked and "lunch" meats, carbon tetrachloride (a solvent found in paints and other products).

Suppressing inflammation inherent in certain forms of cancer. Curcumin inhibits cyclooxygenase (COX) and lipoxygebnaise (LOX), two enzymes that promote inflammation believed to play a significant role in the development and progression of cell carcinoma and colon cancer.

A Strong Antioxidant. Curcumin protects our cells against free radicals that promote cancer and cause aging by damaging DNA and activating genes. In a recent laboratory study, curcumin protected bacteria from a lethal dose of radiation almost flawlessly.

Destroying Abnormal Pre-cancerous Cells. Stops certain forms of cancer by inducing "aptosis," a process that identifies cancerous cells and instructs them to self-destruct.

Stopping Cancer Cells from Multiplying. Stops the growth of cancer cells in the advanced stages of cancer development.

Enhancing Immunity Shown to stimulate both localized and general immunity including CD4 + T-helper and By type immune cells.

Inhibiting Angiogenesis, or the process by which tumors create their own blood supply. Curcumin inhibits the enzyme critical to the process and by blocking iron and copper from the bloodstream, which are required for the growth of blood vessels that the tumors require.


References:
1. On tumor cells in a lab dish, curcumin prevents or slows prostate and lung cancer. But dietary consumption of turmeric, researchers report, so far shows no effect on those organs and failed to inhibit tobacco-induced tumors (Cancer Lett 1999 Apr 1;137(2):123-30).

2. Recent studies have found that curcumin has a dose-dependent chemo-preventive effect in rats during promotion/progression stages of colon cancer (Cancer Res 1999 Feb 1; 59(3): 597-601). It has similar preventive effects against skin cancer, oral cancer and forestomach and other intestinal tumors (J Surg Res 2000 Apr; 89(2): 169-75).

3. According to Tufts researchers, "a mixture of curcumin and isoflavonoids is the most potent inhibitor against the growth of human breast tumor cells. These data suggest that combinations of natural plant compounds may have preventive and therapeutic applications against the growth of breast tumors induced by environmental estrogens" (Environ Health Perspect 1998 Dec;106(12):807-12)

4. Turmeric compares with soy, licorice, red clover, and thyme in binding to progestrone and estrogen receptors in breast cancer cells (Proc Soc Exp Biol Med 1998 Mar;217(3):369-78).

4. Kentucky researchers found that curcumin "inhibited proliferation of a variety of B lymphoma cells" (Clin Immunol 1999 Nov;93(2):152-61).

5. Curcumin may or may not protect against cellular damage from radiation, perhaps depending on dose. It appears to protect against damage to certain organs brought about by some chemotherapy agents. In hamsters it protects the kidneys from Adriamycin (Br J Pharmacol 2000 Jan;129(2):231-4). If you are taking radiation or chemotherapy, discuss your diet and use of any antioxidants with your oncologist.

6. Typical dietary amounts of turmeric have an anti-oxidant effect that protects rats from cataracts (Toxicol Lett 2000 Jun 5;115(3):195-204).

7. Curcumin protects rats from liver-damage caused by toxins (J Pharm Pharmacol 2000 Apr; 52(4): 437-40; Carcinogenesis 2000 Feb; 21(2): 331-5)

From:   http://youngagain.com/marcella75/cumin1.html


Reply
 Message 5 of 11 in Discussion 
From: ReneSent: 4/28/2006 5:16 PM
 


Curry Spice Could Slow Alzheimer's, Study Shows
By E. J. Mundell


NEW YORK (Reuters Health) - Diets rich in curcumin--a compound found in the curry spice turmeric--may help explain why rates of Alzheimer's disease are much lower among the elderly in India compared with their Western peers.

Alzheimer's disease is characterized by the buildup of amyloid protein ``plaques'' within the brain. In studies in rats, curcumin ``not only reduces the amyloid, but also reduces the (brain's) response to the amyloid,'' according to researcher Dr. Sally Frautschy of the University of California, Los Angeles.

She presented her findings Thursday at the annual meeting of the Society for Neuroscience in San Diego, California.

Previous studies have noted that elderly individuals living in Indian villages appear to have the lowest incidence of Alzheimer's disease in the world, with just 1% of those aged 65 and older contracting the degenerative brain condition. The reasons for this low incidence remain unclear, however.

Frautschy speculated that curcumin found in curry could provide a clue to this puzzle since the compound has ``a long history of dietary and herbal medicinal use'' and is also a powerful antioxidant and anti-inflammatory agent. In her study, Frautschy fed middle-aged (9 months old) and aged (22 months old) rats diets rich in curcumin. All of the rats had received brain injections of amyloid to mimic progressive Alzheimer's disease.

``Curcumin reduced the accumulation of beta-amyloid and the associated loss of proteins'' in the synapses, or gaps, between individual brain cells, Frautschy reported.

``Synapses connect nerve cells and are crucial for memory,'' the California researcher explained. Keeping synapses free of plaque is important because ``their loss correlates well with memory decline in Alzheimer's.'' This type of memory preservation may have been reflected in the fact that rats fed curcumin also performed much better in memory-dependent maze tests compared with rats on normal diets, according to Frautschy. Curcumin also appeared to reduce Alzheimer's-related inflammation in neurologic tissue.

Because ``a combined anti-inflammatory and antioxidant approach will be useful for Alzheimer's prevention or treatment,'' Frautschy speculates that curcumin could be especially valuable in the fight against the disease, especially in combination with anti-inflammatory drugs like ibuprofen. Her team is hopeful they will soon receive funding for clinical trials to investigate curcumin-ibuprofen combination therapy.

Curcumin may not be the only compound in the kitchen spice rack able to ward off Alzheimer's. In an interview with Reuters Health, Frautschy said that ``chemicals from rosemary (rosmarinic acid) and ginger (vanillin and zingerone, also high in Indian diets) have similar structure and should be tested.''

 

Summary of Study:

The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse.

Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM.

Departments of Medicine and Neurology, University of California, Los Angeles, Los Angeles, California 90095, and Greater Los Angeles Veterans Affairs Healthcare System, Geriatric Research, Education and Clinical Center, Sepulveda, California 91343.

Inflammation in Alzheimer's disease (AD) patients is characterized by increased cytokines and activated microglia. Epidemiological studies suggest reduced AD risk associates with long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs). Whereas chronic ibuprofen suppressed inflammation and plaque-related pathology in an Alzheimer transgenic APPSw mouse model (Tg2576), excessive use of NSAIDs targeting cyclooxygenase I can cause gastrointestinal, liver, and renal toxicity. One alternative NSAID is curcumin, derived from the curry spice turmeric. Curcumin has an extensive history as a food additive and herbal medicine in India and is also a potent polyphenolic antioxidant. To evaluate whether it could affect Alzheimer-like pathology in the APPSw mice, we tested a low (160 ppm) and a high dose of dietary curcumin (5000 ppm) on inflammation, oxidative damage, and plaque pathology. Low and high doses of curcumin significantly lowered oxidized proteins and interleukin-1beta, a proinflammatory cytokine elevated in the brains of these mice. With low-dose but not high-dose curcumin treatment, the astrocytic marker GFAP was reduced, and insoluble beta-amyloid (Abeta), soluble Abeta, and plaque burden were significantly decreased by 43-50%. However, levels of amyloid precursor (APP) in the membrane fraction were not reduced. Microgliosis was also suppressed in neuronal layers but not adjacent to plaques. In view of its efficacy and apparent low toxicity, this Indian spice component shows promise for the prevention of Alzheimer's disease.

 

From:   http://youngagain.com/marcella75/cumin.html


Reply
 Message 6 of 11 in Discussion 
From: ReneSent: 5/29/2006 4:29 PM
 

 
Curcumin

Curcumin also restores and protects kidney and liver functions
 BRITISH JOURNAL OF PHARMACOLOGY, 2000, Vol 129, Iss 2, pp 231-234

A study investigated the effect of curcumin on artificially induced kidney disease in rats. Results indicated that treatment with curcumin prevented the kidney injury and restored kidney function. Treatment with curcumin significantly protected against proteinuria, albuminuria, hypoalbuminaemia and hyperlipidaemia. Curcumin inhibited the increase in urinary excretion of N-acetyl-beta-D-glucosaminidase (a marker of kidney tubular injury), fibronectin and glycosaminoglycan and blood cholesterol. The data also demonstrated that curcumin protected against kidney injury by suppressing free radicals and increasing kidney glutathione content and glutathione peroxidase activity (endogenous antioxidants). Curcumin also eliminated kidney microsomal and mitochondrial lipid peroxidation. The data suggest that administration of curcumin is a promising approach in the treatment of kidney disease.

 

Curcumin Concentrated Tumeric Extract is a potent antioxidant with specific antiviral, anti-inflammatory, anti-cancer and cholesterol-lowering effects.

Curcumin is especially recommended for hepatitis C patients. One study found it to be more effective than green tea extract in suppressing viral damage to liver cells. Curcumin induces cancer cell apoptosis or death. Apoptosis can be defined simply as programmed cancer cell death. Cancer researchers are focusing in on agents that induce apoptosis as the next generation of cancer drugs. Many of the nutrients in the cancer treatment protocol such as selenium, vitamin A, green tea and vitamin D3 induce apoptosis.

The most effective nutrient available to induce apoptosis may be curcumin. Curcumin is an antioxidant extract from the spice turmeric that produces a wide range of health benefits. Cancer patients should be taking 2000 mg to 4000 mg a day of curcumin extract with a heavy meal. In a wide range of cancer cells, curcumin has been shown to induce cell shrinkage, chromatin condensation, DNA fragmentation and block cellular signal transduction, all of which are characteristics of apoptosis according to an article published in the journal Nutrition and Cancer USA (26/1 1996).

CURCUMIN
A Powerful and Natural Cancer-Fightng Substance
The Following is a summary of the Laboratory Studies that are showing Curcumin induces many biological effects that fight the development and proliferation of cancer cells


  • Suppressing nuclear factor kappa beta (NF-KB). Cancer cells often over-express NF-KB and use this as a means to proliferate. Curcumin has been shown to suppress NF-KB.
  • Blocking cancer-mimicking chemicals that promote cancer growth. Curcumin blocks estrogen and estogen-mimicking chemicals that promote cell mutation and proliferation. These chemicals are found in our environment and are encounctered daily and include paraquat, a weed killer, notrosamines in cooked and "lunch" meats, carbon tetrachloride (a solvent found in paints and other products).
  • Suppressing inflammation inherent in certain forms of cancer. Curcumin inhibits cyclooxygenase (COX) and lipoxygebnaise (LOX), two enzymes that promote inflammation believed to play a significant role in the development and progression of cell carcinoma and colon cancer.
  • A Strong Antioxidant. Curcumin protects our cells against free radicals that promote cancer and cause aging by damaging DNA and activating genes. In a recent laboratory study, curcumin protected bacteria from a lethal dose of radiation almost flawlessly.
  • Destroying Abnormal Pre-cancerous Cells. Stops certain forms of cancer by inducing "aptosis," a process that identifies cancerous cells and instructs them to self-destruct.
     
    Stopping Cncer Cells from Multiplying. Stops the growth of cancer cells in the advanced stages of cancer development.
  • Enhancing Immunity Shown to stimulate both localized and general immunity including CD4 + T-helper and By type immune cells.
  • Inhibiting Angiogenesis, or the process by which tumors create their own blood supply. Curcumin inhibits the enzyme critical to the process and by blocking iron and copper from the bloodstream, which are required for the growth of blood vessels that the tumors require.


Serving size 2 capsules
1000 mg Turmeric root powder standardized*
95% (950 mg) curcumin
Dosage: Healthy people should take one capsule, once or twice daily with meals. 3-4 capsules can be taken 2X daily with meals by people who have cancer or liver problems.

Caution: Always take with meals because curcumin can cause gastric irritation and ulceration if taken on an empty stomach. Do not take curcumin if you have biliary tract obstruction.


For Further Information go to http://youngagain.com/

 

Reply
The number of members that recommended this message. 0 recommendations  Message 7 of 11 in Discussion 
Sent: 7/15/2006 6:14 PM
This message has been deleted by the manager or assistant manager.

Reply
 Message 8 of 11 in Discussion 
From: ReneSent: 10/4/2006 6:31 PM
 

Dear Reader, A somewhat rare condition might lead researchers to a noninvasive cancer solution for people with a far more common condition: colorectal polyps.

--------------------------------------------
Years in the making
--------------------------------------------

Familial adenomatous polyposis (FAP) is a hereditary condition that affects only about 10,000 people in the U.S. FAP patients typically begin to develop numerous benign polyps in the colon when they're only in their teens.

Polyps continue to multiply into the hundreds and sometimes thousands as FAP patients age. Eventually the polyps become malignant, usually when patients reach their 50s. Before malignancy, polyps can be removed during colonoscopy, although this may not be practical with patients who have very high polyp counts. Once malignancy begins, the colon has to be removed.

Nonsteroidal anti-inflammatory drugs and COX-2 inhibitors can sometimes reverse the progression of polyps, but as I've noted in many e-Alerts, these drugs commonly produce harsh adverse side effects when taken on a regular basis.

--------------------------------------------
Flavorful and pungent
--------------------------------------------

Previous studies have shown that curcumin produces anti-inflammatory effects that may fight cancer.

Curcumin is a yellow pigment in the root of turmeric, an herb in the ginger family. Curry gets its pungent flavor from curcumin, which was used for many centuries by Indian Ayurvedic healers to treat indigestion, arthritis and urinary tract disorders.

Researchers at Johns Hopkins University School of Medicine recently tested the effects of curcumin and quercetin (a plant flavanoid found in apples and onions) on five FAP patients.

STUDY ABSTRACT

All subjects received supplements containing 480 mg of curcumin and 20 mg of quercetin three times each day for six months
The number and size of polyps were evaluated at the beginning and end of the study
Results showed a 60 percent decrease in the number of polyps, on average
The average size of polyps was reduced by more than 50 percent
About halfway through the study, researchers found that one subject had not been taking his supplements. A check of his polyps showed their number had increased. But after restarting the daily supplement regimen, the number of polyps dropped by the end of the trial period.

--------------------------------------------
Handle with care
--------------------------------------------

Johns Hopkins researcher, Francis Giardiello, M.D., told FoodNavigator that the amount of quercetin used in the study was similar to the daily quercetin intake that many people get through a normal diet. But the curcumin intake provided by the supplement was many times higher than the amount of curcumin that could be consumed through dietary intake.

Dr. Giardiello believes that the positive results of the study might be primarily due to the curcumin supplement. He also notes that eating onions and curry won't necessarily produce the same protective effect of supplemental extracts. The Hopkins team is currently planning a large intervention study to further explore the effect of curcumin extract on colon polyps.

Talk to your doctor or a healthcare professional before taking curcumin or quercetin supplements. Although only a few mild side effects were reported in the Hopkins trial, some people experience stomach upset and even ulcers with high doses of curcumin. Also, curcumin is known to thin the blood, so it should not be taken with anti-coagulants or anti-inflammatory drugs.

To Your Good Health, Jenny Thompson

Sources:

"Combination Treatment With Curcumin and Quercetin of Adenomas in Familial Adenomatous Polyposis" Clinical Gastroenterology and Hepatology, Vol. 4, No. 8, August 2006, cghjournal.org


"Curry and Onion Extracts Could Protect Against Colon Cancer" FoodNavigator, 8/2/06, foodnavigator.com
"Teen Cancer Patient's Court Battle Leads to Va. Legislation" Larry O'Dell, The Associated Press, 8/24/06, dailypress.com


August 30, 2006  http://www.hsibaltimore.com/ealerts/freecopy.html


Reply
 Message 9 of 11 in Discussion 
From: ReneSent: 5/1/2007 5:57 PM

Curcumin for Health

Curcumin, the yellow pigment of the spice turmeric, may help fight cancer and other diseases, new studies suggest.

The rhizome (root) of turmeric (Curcuma longa Linn.) has long been used in traditional Asian medicine to treat gastrointestinal upset, arthritic pain, and "low energy." Laboratory and animal research has demonstrated anti-inflammatory, anti-oxidant, and anti-proliferative properties of turmeric and its constituent curcumin. Preliminary human evidence, albeit poor quality, suggests possible efficacy in the management of dyspepsia (upset stomach), hyperlipidemia (high cholesterol) and scabies (topical therapy). However, due to methodological weaknesses in the available studies, an evidence-based recommendation cannot be made regarding the use of turmeric or curcumin for any specific indication.

In traditional Indian Ayurvedic medicine, turmeric has been used to strengthen the body, tone the digestive system and the liver, dispel worms, regulate menstruation, dissolve gallstones and relieve arthritis. Ancient Hindu texts refer to its carminative, aromatic and stimulant properties. Mixed with slaked lime, it has been used as a topical treatment for sprains and strains.

In Chinese medicine, turmeric is an important herb for digestive and urinary complaints, gallstones and menstrual pain. Turmeric has been used in Asian food preparation, medicine, cosmetics and fabric dying for more than 2,000 years. Marco Polo described turmeric in his memoirs, and the herb became popular in Europe during Medieval times for its coloring value and medicinal uses.

A study by researchers from The University of Texas M.D. Anderson Cancer Center found that curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines.

Study authors explained that curcumin is a well-known chemopreventive agent and has been shown to suppress the proliferation of a wide variety of tumor cells through a mechanism that is not fully understood.

Cyclin E, a proto-oncogene that is overexpressed in many human cancers, mediates the G(1) to S transition, is a potential target of curcumin. Researchers demonstrated a dose- and time-dependent down-regulation of expression of cyclin E by curcumin that correlates with the decrease in the proliferation of human prostate and breast cancer cells. The suppression of cyclin E expression was not cell type dependent as down-regulation occurred in estrogen-positive and -negative breast cancer cells, androgen-dependent and -independent prostate cancer cells, leukemia and lymphoma cells, head and neck carcinoma cells, and lung cancer cells.

Curcumin-induced down-regulation of cyclin E was reversed by proteasome inhibitors, lactacystin and N-acetyl-L-leucyl-L-leucyl-L-norleucinal, suggesting the role of ubiquitin-dependent proteasomal pathway. Researchers found that curcumin enhanced the expression of tumor cyclin-dependent kinase (CDK) inhibitors p21 and p27 as well as tumor suppressor protein p53 but suppressed the expression of retinoblastoma protein. Curcumin also induced the accumulation of the cells in G1 phase of the cell cycle.

Researchers concluded that proteasome-mediated down-regulation of cyclin E and up-regulation of CDK inhibitors may contribute to the antiproliferative effects of curcumin against various tumors.

In a related study, researchers from The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia-St. Paul's Hospital in Canada, investigated the anti-inflammatory, antioxidant and antiproliferative properties or curcumin.

Researchers found that curcumin inhibits several intracellular signaling pathways, including the mitogen-activated protein kinases (MAPKs), casein kinase II (CKII), and the COP9 signalosome (CSN), in various cell types. Researchers noted that it has also been recently demonstrated that exposure to curcumin leads to the dysregulation of the ubiquitin-proteasome system (UPS).

Coxsackievirus infection is associated with various diseases, including myocarditis (inflammation of heart muscle) and dilated cardiomyopathy (weakness of heart muscle).

In searching for new antiviral agents against coxsackievirus, researchers found that treatment with curcumin significantly reduced viral RNA expression, protein synthesis and virus titer and protected cells from virus-induced cytopathic effect and apoptosis.

The study demonstrated that reduction of viral infection by curcumin was unlikely due to inhibition of CVB3 binding to its receptors or CVB3-induced activation of MAPKs. Moreover, said study authors, gene silencing of CKII and Jab1, a component of CSN, by small interfering RNAs did not inhibit the replication of coxsackievirus, suggesting that the antiviral action of curcumin is independent of these pathways.

Lastly, researchers found that curcumin treatment reduced both the 20S proteasome proteolytic activities and the cellular deubiquitinating activities, leading to increased accumulation of ubiquitinated proteins and decreased protein levels of free ubiquitin.

Researchers concluded that there may be an important antiviral effect of curcumin wherein it potently inhibits coxsackievirus replication through dysregulation of the UPS.

 

References:

1) Aggarwal BB, Banerjee S, Bharadwaj U, et al. Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem Pharmacol. 2007 Apr 1;73(7):1024-32. Epub 2006 Dec 15.

2) Si X, Wang Y, Wong J, et al. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. J Virol. 2007 Apr;81(7):3142-50. Epub 2007 Jan 17.

3) Natural Standard Research Collaboration: The Authority on Integrative Medicine. [www.naturalstandard.com] Copyright © 2007.


Reply
 Message 10 of 11 in Discussion 
From: MSN NicknameBlue_Opal2003Sent: 6/29/2007 12:47 AM
 
 
Life Is a Bowl of Curries

Used for centuries in India to treat indigestion, turmeric was considered just another culinary spice in the West until researchers discovered it contained a potent anti-inflammatory and antioxidant compound called curcumin. Since then, studies in-vitro and in mice have established curcumin’s ability to fight inflammation and inhibit human colon cancer cells. A recent pilot study of five people with ulcerative proctitis and five with Crohn’s disease found that daily treatments with a standardized dose of curcumin (550 mg twice a day for one month, then three times a day for ulcerative proctitis; 360 mg three times a day for one month and then four times a day for Crohn’s disease) over a two- or three-month period brought significant improvement in both groups. The researchers say the results warrant a full-blown double-blind, placebo-controlled study. In the meantime, it couldn’t hurt for anyone with Irritable Bowel Syndrome or other intestinal issues to add a dose of curcumin to their daily supplement intake. Hate swallowing pills? Try adding yellow curry and other turmeric-rich dishes to your diet for a tummy-friendly boost.
—James Keough
 
 
Courtesy of Alternative Medicine
[http://www.alternativemedicine.com] 

Reply
 Message 11 of 11 in Discussion 
From: ReneSent: 9/4/2007 4:20 AM


Curcumin May Hold Cure for Neuromuscular Disease

March 21, 2007

The Journal of Nature reports that researchers at the University of Rochester Medical Center have found that curcumin ,a compound that is a component found in spice curry, may hold the cure for a debilitating neurodegenerative condition known as Kennedy's disease.

The disease, which is caused by a mutant gene, currently has no cure, and is an inherited disorder that affects only men.

Boffins led by Chawnshang Chang, Ph.D. conducted a study on a mouse model and found that curcumin - the bright yellow spice found in curry powder which has traditionally been used in Asian countries to treat a variety of ills, dramatically slowed the progression of the disease in mice that carried the mutant human gene that causes the disease.

As a part of their study the researchers tested hundreds of compounds, including ASC-J9, a synthetic chemical compound that is loosely based on a compound found in curcumin.

The researchers noted that when mice carrying the human gene that were treated with ASC-J9, they experienced a remarkable improvement.

The rodents were not only more mobile than their untreated counterparts, but were also walking more normally and dragging their legs less often.

Their muscles appeared to work normally, and they lived 40 percent longer than the untreated mice. In addition, the mice treated with ASC-J9 were able to mate and produce offspring, while their counterparts could not.

However, Chang warns that the compound had been 'significantly modified', and that it still needed to be tested on humans.

"The compound we are studying has been significantly modified from the original ingredient found in food like curry or ginger. It still must be tested in people. We certainly don't want to mislead people to think these foods themselves have any benefit for Kennedy's disease," Nature quoted him, as saying.

The researchers also found that the amount of abnormal clumps in the neurons and spinal cords of the mice was slashed by half, and that VEGF, a growth factor that is crucial for life and essential to the health of motor neurons, activity in the neurons went up more than four times in the treated mice compared to untreated mice.

"Traditionally, when scientists have wanted to affect the androgen receptor, they have taken away substances like testosterone that bind to and activate the receptor," said Chang.

"But this can cause many unwanted, systemic side effects. We take another approach: Instead of taking away the substances that turn on the receptor, we look for ways to attack the faulty receptor directly. In this experiment, for instance, the mice treated with ASC-J9 have normal fertility and are completely healthy sexually, which wouldn't be the case if we simply took away testosterone," he added.

The study appears in the March issue of the journal Nature Medicine.

From: Your Favorite Health Spot Has Changed Its Name To SupplementSpot.Com

 


First  Previous  2-11 of 11  Next  Last 
Return to Herbs etc